Correlation Between Griffon and Astrazeneca

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Griffon and Astrazeneca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Griffon and Astrazeneca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Griffon and Astrazeneca Ab, you can compare the effects of market volatilities on Griffon and Astrazeneca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Griffon with a short position of Astrazeneca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Griffon and Astrazeneca.

Diversification Opportunities for Griffon and Astrazeneca

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Griffon and Astrazeneca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Griffon and Astrazeneca Ab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astrazeneca Ab and Griffon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Griffon are associated (or correlated) with Astrazeneca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astrazeneca Ab has no effect on the direction of Griffon i.e., Griffon and Astrazeneca go up and down completely randomly.

Pair Corralation between Griffon and Astrazeneca

If you would invest  6,980  in Griffon on September 12, 2024 and sell it today you would earn a total of  1,005  from holding Griffon or generate 14.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Griffon  vs.  Astrazeneca Ab

 Performance 
       Timeline  
Griffon 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Griffon are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Griffon reported solid returns over the last few months and may actually be approaching a breakup point.
Astrazeneca Ab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astrazeneca Ab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Astrazeneca is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Griffon and Astrazeneca Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Griffon and Astrazeneca

The main advantage of trading using opposite Griffon and Astrazeneca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Griffon position performs unexpectedly, Astrazeneca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astrazeneca will offset losses from the drop in Astrazeneca's long position.
The idea behind Griffon and Astrazeneca Ab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets